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The propagation of pluripotent mouse embryonic stem (ES) cells depends on signals transduced through the cytokine
receptor subunit gp130. Signalling molecules activated downstream of gp130 in ES cells include STAT3, the protein tyrosine
phosphatase SHP-2, and the mitogen-activated protein kinases, ERK1 and ERK2. A chimaeric receptor in which tyrosine 118
in the gp130 cytoplasmic domain was mutated did not engage SHP-2 and failed to activate ERKs. However, this receptor did
support ES cell self-renewal. In fact, stem cell colonies formed at 100-fold lower concentrations of cytokine than the
unmodified receptor. Moreover, altered ES cell morphology and growth were observed at high cytokine concentrations.
These indications of deregulated signalling in the absence of tyrosine 118 were substantiated by sustained activation of
STAT3. Confirmation that ERK activation is not required for self-renewal was obtained by propagation of pluripotent ES
cells in the presence of the MEK inhibitor PD098059. In fact, the growth of undifferentiated ES cells was enhanced by
culture in PD098059. Thus activation of ERKs appears actively to impair self-renewal. These data imply that the
self-renewal signal from gp130 is a finely tuned balance of positive and negative effectors. © 1999 Academic PressKey Words: ES cells; self-renewal; gp130; SHP-2; STAT3; ERK.INTRODUCTION
The mammalian embryo develops from a founder popu-
lation of pluripotent stem cells, the epiblast. These rapidly
dividing stem cells persist only transiently in vivo, differ-
ntiating to form extraembryonic mesoderm and the three
erm layers of the embryo proper during gastrulation.
owever, epiblast cells are intrinsically immortal and can
ive rise to stem cell tumours, teratocarcinomas, when
rafted to ectopic sites (Solter et al., 1970). Furthermore,
when the epiblast of a mouse blastocyst is explanted in
culture, immortal embryonic stem (ES) cell lines can be
isolated (Brook and Gardner, 1997; Evans and Kaufman,
1981; Martin, 1981).
Propagation of ES cells is dependent on the presence of
the cytokine LIF (Smith et al., 1988; Smith and Hooper,
1987; Stewart et al., 1992; Williams et al., 1988). LIF
promotes the proliferation of undifferentiated stem cells
through the activation of a heteromeric complex containing
two related cytokine receptor subunits, gp130 and the
low-affinity LIF receptor, LIF-R (Davis et al., 1993; Gearing
and Bruce, 1992; Gearing et al., 1991). Homodimerisation of
gp130 alone, in response to the cytokine interleukin-6 (IL-6)
30and a soluble form of IL-6 receptor (sIL-6R), can also support
the derivation and propagation of ES cell lines (Nichols et
al., 1994; Yoshida et al., 1994). A functional analysis of
signals transduced through gp130 therefore provides an
opportunity to elucidate the molecular mechanisms that
regulate the propagation of ES cells and underpin pluripo-
tency.
Signal transduction via gp130 depends upon the activa-
tion of JAK kinases, a class of nonreceptor tyrosine kinases
that associate with the membrane proximal box1/box2
region of cytokine receptors (Darnell et al., 1994). Upon
activation, JAKs phosphorylate tyrosines in the intracellu-
lar domain of gp130 creating binding sites for proteins
containing Src-homology-2 (SH2) domains. These proteins
can in turn be phosphorylated, resulting in the activation of
a variety of signalling molecules, including STATs (signal
transducer and activator of transcription) 1 and 3 (Stahl et
al., 1995), the tyrosine phosphatase SHP-2, the mitogen-
activated protein kinases (MAPK) ERK1 and ERK2 (Fukada
et al., 1996), insulin receptor substrate-1(IRS-1) (Argetsinger
et al., 1995), Grb2-associated docking protein (Gab1) and
phosphatidylinositol (PI)-3 kinase (Takahashi-Tezuka et al.,
1998), and the nonreceptor tyrosine kinases Hck and Btk
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31SHP-2 and ERK Activity in Pluripotent Cells(Ernst et al., 1994; Matsuda et al., 1995). Amongst these, the
TAT and MAPK signalling pathways appear to be the
rincipal mediators of the biological responses to ligands
hat activate gp130 (Fukada et al., 1996; Minami et al.,
996; Nakajima et al., 1996; Sheng et al., 1997; Shimozaki
t al., 1997).
STATs are a family of latent transcription factors that
pon recruitment to a receptor become phosphorylated,
imerise, and then translocate to the nucleus where they
egulate transcription of target genes (Darnell, 1997). We
ave recently shown that activation of STAT3 is required
or maintaining the pluripotent phenotype of ES cells (Niwa
t al., 1998). Chimaeric gp130 receptors unable to engage
TAT3 were incapable of signalling self-renewal, whilst
verexpression of a STAT3 interfering mutant caused ES
ells to differentiate. However, in the absence of constitu-
ively active forms of STAT3, we have been unable to
etermine whether this regulator alone is sufficient or if
ther signals are also required for self-renewal.
gp130 can also associate with the protein tyrosine phos-
hatase SHP-2 (Fukada et al., 1996). This widely expressed
nzyme has been implicated in signal transduction from
eceptor tyrosine kinases and is regarded as a positive
ffector of the MAPK signalling cascade (reviewed in Van
actor et al., 1998). SHP-2 contains a C-terminal catalytic
domain and two tandemly arranged SH2 domains at its N
terminus. The most N-terminal SH2 domain binds to one of
the phosphorylated tyrosines on gp130, situated 118 amino
acid residues from the membrane (Symes et al., 1997). This
interaction both recruits SHP-2 to the receptor complex and
causes a conformational change which increases its cata-
lytic activity (Hof et al., 1998). Genetic and biochemical
studies in Drosophila have identified the Daughter of
Sevenless (DOS) protein as a substrate for corkscrew, the
Drosophila homologue of SHP-2, and have shown a require-
ment for DOS in receptor tyrosine kinase signalling (Herbst
et al., 1996). Interestingly, a mammalian homologue of
DOS, Gab1, has been shown to interact with SHP-2
(Holgado-Madruga et al., 1996; Takahashi-Tezuka et al.,
1998). Recent evidence suggests that engagement of the
gp130 receptor subunit results in the formation of a com-
plex containing SHP-2, Gab1, and PI-3 kinase, resulting in
activation of PI-3 kinase and of ERKs (Takahashi-Tezuka et
al., 1998). In addition, tyrosine phosphorylation of SHP-2
following recruitment to gp130 can create binding sites for
the adaptor protein Grb2, which may also couple gp130 to
the ERK pathway through interactions with SOS and Ras
(Fukada et al., 1996; Li et al., 1994).
Stimulation of ERK1 and ERK2 has been shown to play a
key role in mediating mitogenic responses of cells to
growth factors (Cowley et al., 1994; Pages et al., 1993;
Vouret-Craviari et al., 1993; Weber et al., 1997). Activation
of this pathway via gp130 has also been reported to promote
the proliferation of BAF B03 cells and to block apoptosis in
cardiomyocytes (Fukada et al., 1996; Sheng et al., 1997).
Here we confirm that activation of gp130 does stimulate
the phosphorylation of SHP-2 and activation of ERK1 and
N
Copyright © 1999 by Academic Press. All rightERK2 in ES cells. Surprisingly, however, these signals are
not required for the efficient propagation of stem cells. On
the contrary, elimination of the phosphotyrosine binding
site for SHP-2 from gp130 or inhibition of ERK activation
enhanced ES cell self-renewal.
MATERIALS AND METHODS
ES Cell Culture and Transfection
ES cells were maintained without feeder cells in Glasgow
modification of Eagle’s medium containing 10% foetal calf serum,
0.1 mM 2-mercaptoethanol, and LIF. D027 cells have both copies of
the lif gene inactivated by homologous recombination and an
IRES-bgeo reporter gene inserted within the Oct4 gene locus (Dani
et al., 1998). ZIN40 cells carry a nuclear-localised b-galactosidase
marker gene that is widely expressed in differentiated cell types
(Mountford, 1995). For transfections of D027 cells, 2 3 107 cells
ere electroporated with 100 mg of linearised plasmid DNA at 0.8
kV and 3 mF in a 0.4-cm cuvette using a Bio-Rad gene pulser. Stably
transfected clones were selected in medium containing 20 mg/ml
zeocin (Invitrogen). For introduction of the episomal constructs
into MG1.19 cells (Gassmann et al., 1995), 5 3 106 cells were
electroporated with 20 mg of supercoiled plasmid DNA at 0.2 kV
nd 960 mF. Stably transfected colonies were selected in medium
ontaining 100 mg/ml hygromycin B for 8 days.
Plasmid Construction
The GRgp130 chimaeric receptors were generated by fusing the
extracellular domain of the human granulocyte colony stimulating
factor receptor (G-CSFR) (Baumann et al., 1994) to an EcoRI
ragment of mouse gp130 containing the transmembrane domain
nd the entire cytoplasmic region (Hibi et al., 1990). The phenyl-
lanine substitution of tyrosine 118 was introduced into the
ntracellular domain of gp130 by PCR overlap mutagenesis (Higu-
hi et al., 1988). The PCR product was substituted into the
Rgp(278) chimaera and sequenced. The receptor cDNAs were
nserted within expression vector pCAGIZ. This vector contains a
icistronic expression cassette consisting of cytomegalovirus
nhancer-human b-actin promoter, a site for insertion of the
receptor cDNA, an internal ribosome entry site, and the zeocin-
resistance gene (Niwa et al., 1998). Full-length cDNAs encoding
human SHP-2 (Bennett et al., 1996) were inserted into both
pCAGIZ and an otherwise identical plasmid, pCAGIH, in which
the zeocin-resistance gene was substituted by the hygromycin-
resistance gene.
Self-Renewal Assay
Expression of b-galactosidase from the Oct4 locus in D027 cells
was quantitated in an ONPG assay. ES cells were plated at 5000
cells per well in 24-well dishes and cultured for 6 days in the
presence or absence of cytokine. When cells were treated with
PD098059, they were plated at 2500 per well and cultured over-
night in normal growth medium prior to addition of the inhibitor.
On day 6, cells were washed once with PBS and lysed in 0.4 ml of
0.25 M Tris, pH 7.5, 0.5 mM DTT, 0.5% NP-40. Lysate (40 ml) was
ixed with 100 ml of ONPG buffer (60 mM Na2HPO4, 40 mM
aH2PO4, 10 mM KCl, 1 mM MgCl2, 50 mM 2-mercaptoethanol,
1.2 mM ONPG) in a microtitre plate and incubated at 37°C for 2–4
s of reproduction in any form reserved.
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32 Burdon et al.h and the absorbance was read at 420 nm. All assays were
performed in triplicate.
Immunoprecipitation and Immunoblotting
One day after plating (2–3 3 106 cells per 100-mm dish), ES cells
ere refed with medium containing 1% foetal calf serum and
acking cytokines. The following day, cells were transferred to
erum-free medium for 4 h prior to stimulation with IL-6 (100
g/ml plus soluble receptor) or G-CSF (30 ng/ml) for 15 min. Cells
ere then washed once with ice-cold PBS and scraped off in 1 ml of
ce-cold lysis buffer (150 mM NaCl, 10 mM Tris–HCl, pH 7.4, 0.5%
P-40, 1 mM NaVO3, 1 mM EDTA, 0.5 mM PMSF). Cleared
lysates were incubated with 1 mg anti-SHP-2 antibody (Santa Cruz)
t 4°C for 1 h and then protein A–Sepharose was added and the
ncubation continued overnight. Immunoprecipitates were solu-
ilised in 23 SDS sample buffer, electrophoresed on a 10% SDS–
olyacrylamide gel, and electroblotted onto nitrocellulose. After
vernight treatment with blocking buffer (25 mM Tris–HCl, pH
.4, 2.7 mM KCl, 140 mM NaCl, 0.1% Tween 20, 1% BSA) the
embranes were probed sequentially with anti-phosphotyrosine
G10 (Transduction Laboratories), anti-Gab1 (Takahashi-Tezuka
t al., 1998), and anti-SHP-2 antibodies (Santa Cruz). Blots were
ncubated with horseradish peroxidase-coupled anti-mouse or anti-
abbit IgG and developed using ECL reagents (Amersham). Anti-
odies were stripped from the membranes between probings by
ncubation at 50°C for 30 min in 62.5 mM Tris–HCl, pH 6.8, 2%
DS, 100 mM 2-mercaptoethanol.
For analysis of STAT3 and ERK phosphorylation, 1 3 106 ES cells
ere plated per well of 6-well dishes. Cells were serum starved and
reated with cytokines as described above and then lysed in 100 ml
SDS sample buffer. Ten-microlitre aliquots were fractionated on a
10% SDS–polyacrylamide gel, electroblotted onto nitrocellulose,
and probed with anti-ERK and anti-STAT3 antibodies according to
the directions provided by the supplier (New England Biolabs).
Chimaera Analysis
ZIN40 ES cells (Mountford, 1995) were injected into C57BL/6
blastocysts and transferred into pseudopregnant mice. Mice were
sacrificed at day 9.5 of pregnancy and the embryos were stained
with X-gal.
Formation of Embryoid Bodies
Trypsinised IOUD2 ES cells (Dani et al., 1998) were diluted to
1.5 3 104 cells/ml and allowed to aggregate in 10-ml hanging drop
cultures for 2 days in the absence of LIF. They were then transferred
to bacterial dishes containing medium with or without PD098059.
After 5 days of culture, the embryoid bodies were collected and
plated overnight in gelatine-coated wells of a 6-well tissue culture
dish. Embryoid bodies were either stained with X-gal on the
following day or cultured for a further 5 days and then stained.
RESULTS
Tyrosine 118 Is Required for gp130-Dependent
Phosphorylation of SHP-2 in ES CellsPrevious studies in BAF pro-B cell lines have shown that
gp130-dependent activation of SHP-2 and the MAPKs,
c
g
Copyright © 1999 by Academic Press. All rightRK1 and ERK2, is mediated via a tyrosine located 118
mino acid residues from the membrane within the cyto-
lasmic region of gp130 (Fukada et al., 1996). To examine
he functional role of tyrosine 118 in ES cells, we con-
tructed cDNAs encoding chimaeric receptors consisting of
he extracellular domain of the G-CSFR fused to the trans-
embrane and cytoplasmic region of gp130. Since ES cells
o not normally express the G-CSFR and show no self-
enewal response to G-CSF (data not shown), these chimae-
ic receptors can be used to examine signalling independent
f endogenous cytokine receptors (Niwa et al., 1998).
DNAs encoding either the unmodified chimaeric receptor,
Rgp(278), or a mutated receptor in which phenylalanine
ad been substituted for tyrosine 118, GRgp(Y118F), were
loned into the pCAGIZ expression vector and stably intro-
uced into D027 ES cells by electroporation.
In several differentiated cell types, SHP-2 becomes ty-
osine phosphorylated following its recruitment to a ty-
osine phosphorylated gp130 receptor subunit (Fukada et
l., 1996; Nakashima et al., 1997; Stahl et al., 1995). To
xamine whether SHP-2 undergoes this modification in ES
ells, SHP-2 immunoprecipitates were prepared from
Rgp(278) and GRgp(Y118F) transfectants following stimu-
ation with either IL-6 (plus sIL-6R) or G-CSF and probed for
hosphotyrosine by Western blotting (Fig. 1). An increase in
hosphorylated SHP-2 was detected in cells stimulated
hrough either the endogenous gp130 or the GRgp(278)
eceptor. Two additional tyrosine phosphoproteins copre-
FIG. 1. gp130-dependent phosphorylation of SHP-2 in ES cells. ES
cells expressing either the GRgp(278) or the GRgp(Y118F) chimae-
ric receptors were induced with IL-6 (100 ng/ml plus sIL-6R) or
G-CSF (30 ng/ml) for 15 min. SHP-2 protein was immunoprecipi-
tated from lysates of unstimulated or stimulated cells, fractionated
on a SDS–polyacrylamide gel, and transferred to a nitrocellulose
membrane. The filter was probed sequentially with anti-
phosphotyrosine antibody (top), anti-Gab1 antibody (middle), and
anti-SHP-2 antibody (bottom). The positions of tyrosine-
phosphorylated forms of SHP-2, Gab1, and the higher molecular
weight tyrosine phosphoprotein are indicated by arrows.ipitated with the phosphorylated SHP-2. The protein mi-
rating at approximately 100 kDa represents Gab1, an
s of reproduction in any form reserved.
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33SHP-2 and ERK Activity in Pluripotent CellsIRS-1-related adaptor protein previously reported to associ-
ate with phosphorylated SHP-2 (Holgado-Madruga et al.,
1996; Takahashi-Tezuka et al., 1998; Weidner et al., 1996),
while the higher molecular weight phosphoprotein likely
represents phosphorylated receptor. Phosphorylation of
SHP-2 did not increase following stimulation of the
GRgp(Y118F) receptor, indicating that tyrosine 118 is nec-
essary for recruitment of the phosphatase to gp130 in ES
cells.
SHP-2 Activation Is Not Required for ES Cell
Self-Renewal
In order to determine whether activation of SHP-2 is
FIG. 2. Effect of mutating tyrosine 118 on gp130-dependent sel
GRgp(278) and GRgp(Y118F) chimaeric receptors in response to G-
Oct4–LacZ locus was assayed after 6 days in culture with G-CSF (3
as means 6 SEM for duplicate determinations of triplicate samples
(B) Photomicrographs of X-gal-stained, representative colonies form
with 300 fg, 30 pg, and 30 ng/ml of G-CSF. (C) Photomicrograp
transfectants after 6 days culture with no cytokine, IL-6 (100 ng/ml
g/ml).necessary for the propagation of ES cells, the response of
GRgp130 transfectants to G-CSF was measured in a self-
Copyright © 1999 by Academic Press. All rightenewal assay. D027 cells have a LacZ gene inserted within
he stem-cell-specific gene, Oct4 (Dani et al., 1998). As a
consequence, expression of this integrated reporter gene is
restricted to undifferentiated ES cells and the resulting
b-galactosidase activity provides a measure of stem cell
self-renewal. In addition, both copies of the lif gene have
een inactivated through gene targeting, thus reducing
utocrine stimulation of ES cell growth (Dani et al., 1998).
b-Galactosidase activity from two independently isolated
clones for each receptor construct was measured in
medium-density cultures after 6 days of treatment with 300
fg/ml to 30 ng/ml G-CSF.
The data presented in Fig. 2A show that self-renewal of
GRgp(278) transfectants increased in a dose-dependent
ewal and growth of ES cells. (A) Stem cell renewal mediated by
Self-renewal, as measured by b-galactosidase expression from the
/ml to 30 ng/ml). Data for two independent clones are represented
alised relative to the response with IL-6 (100 ng/ml plus sIL-6R).
by GRgp(278) and GRgp(Y118F) transfectants after 6 days culture
representative colonies formed by GRgp(278) and GRgp(Y118F)
-6R), G-CSF(30 ng/ml), or IL-6 (100 ng/ml 1 sIL-6R) and G-CSF(30f-ren
CSF.
00 fg
norm
ed
hs ofmanner, reaching a plateau at 3–30 ng/ml G-CSF. In con-
trast, the maximal self-renewal response of GRgp(Y118F) ES
s of reproduction in any form reserved.
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35SHP-2 and ERK Activity in Pluripotent Cellscells was achieved at just 30 pg/ml G-CSF. The morphology
of the GRgp(Y118F) colonies maintained in 30 pg/ml G-CSF
was typical of undifferentiated ES cells (Fig. 2B). This result
establishes that activation of SHP-2 through tyrosine 118 is
not required to direct ES cell self-renewal. Equivalent levels
of both receptor chimaeras were expressed at the cell
surface of ES cell transfectants, as judged by binding studies
with 125I-labelled G-CSF (data not shown). Therefore the
hift in dose response suggests that substitution of Y118
irectly alters signalling activity.
Interestingly, at higher concentrations of G-CSF,
Rgp(Y118F) transfectants formed small aggregates of cells
ather than the more flattened colony morphology normally
ssociated with undifferentiated ES cells (Fig. 2B). These
olonies expressed b-galactosidase and stained positive for
the stem cell marker alkaline phosphatase (Fig. 2B and data
not shown), indicating that the ES cells remained undiffer-
entiated. This was confirmed by the resumption of typical
ES cell growth and colony morphology when, following
treatment with G-CSF, these cultures were refed with
medium containing IL-6 plus sIL-6R (data not shown).
The unusual appearance of GRgp(Y118F) cells in high con-
centrations of G-CSF is unlikely to be simply due to an
increase in affinity of the Y118F receptor for G-CSF because
this response is not observed in wild-type cells treated with
high levels of LIF or in GRgp(278) transfectants treated with
saturating levels of IL-6 (plus sIL-6R), G-CSF, or IL-6 (plus
sIL-6R) plus G-CSF (Fig. 2C). Furthermore the phenotype of
GRgp(Y118F) cells in high levels of G-CSF was maintained
when cells were simultaneously stimulated with G-CSF and
IL-6 (plus sIL-6R). This observation excludes the explanation
that the unusual ES cell morphology is due to a partial loss of
self-renewal signals and suggests that the phenotype arises
from hyperactivation of signals downstream of gp130. Collec-
tively these data point to a key role for tyrosine 118 in
downregulating gp130 signalling in ES cells.
Attenuation of the STAT3 Signal Is Mediated via
Tyrosine 118
We have previously established that activation of STAT3 is
essential for gp130-dependent self-renewal of ES cells (Niwa et
l., 1998). To determine whether mutating tyrosine 118 af-
ects this key regulator, activation of STAT3 was compared in
Rgp(278) and (Y118F) transfectants. Stimulation of cells for
5 min with 30 fg/ml to 300 ng/ml of G-CSF did not reveal a
ignificant difference between the levels of tyrosine phosphor-
lation of STAT3 induced by the chimaeric receptors (data not
hown). However, signalling through the receptors was distin-
uished when the duration of the STAT3 signal was examined
Fig. 3). Cells were stimulated with either G-CSF or IL-6 (plus
IL-6R) for 25 min and refed with cytokine-free medium and
hen samples were collected at 40-min intervals. A similar
ime course for the decay of phosphorylated STAT3 was
btained following stimulation through either the endoge-
ous gp130 receptor or GRgp(278), with the signal being
ndetectable by 120 min. In contrast, the activation of STAT3
Copyright © 1999 by Academic Press. All rightas sustained in G-CSF-treated GRgp(Y118F) cells and could
till be detected at 160 min. This result indicates that tyrosine
18 mediates a signal that normally attenuates the activation
f STAT3.
Inhibition of SHP-2 Activity Promotes ES Cell
Self-Renewal
To determine whether the inability to recruit and activate
SHP-2 could account for the altered regulation of the
GRgp(Y118F) receptor, we examined the effects of overex-
pressing mutated forms of SHP-2 on ES cell self-renewal.
SHP-2 can potentially affect downstream signalling through
two mechanisms; through its phosphatase activity or via
direct phosphotyrosine-dependent interaction with the SH2
domain containing adaptor protein Grb2 (Bennett et al., 1994;
Milarski and Saltiel, 1994). cDNAs encoding wild-type SHP-2,
a mutant lacking the two principal sites for tyrosine phosphor-
ylation on SHP-2 (Y542/580F), or a catalytically inactive
enzyme in which an essential cysteine is replaced with serine
(C459S) were inserted into the pCAGIH expression vector.
These plasmids contain the polyoma origin of replication and
are maintained as episomes when introduced into MG1.19
cells, an ES cell line that has been engineered to constitutively
express polyoma large T (Gassmann et al., 1995). In addition
to the relatively stable expression of the introduced cDNA,
the transfection efficiency of these vectors is considerably
higher than protocols dependent on stable integration, thus
allowing rapid evaluation of the effects of introduced mol-
ecules in large numbers of independent transfectants (Niwa et
al., in preparation).
FIG. 3. Decay of activated STAT3 following stimulation of gp130
and the chimaeric GRgp130 receptors. GRgp(278) and GRgp(Y118F)
ES cell transfectants were stimulated with IL-6 (100 ng/ml plus
sIL-6R) or G-CSF (30 ng/ml) for 25 min (0*) and refed with
cytokine-free medium and samples were collected at 40-min inter-
vals. Immunoblots of cell lysates were probed sequentially with an
antibody specific for the active phosphorylated form of STAT3 and
then with an antibody that recognises both phosphorylated and
unphosphorylated STAT3. Note that activation of STAT3 is asso-
ciated with the appearance of a slower migrating STAT3 species,
presumed to be the serine phosphorylated form of STAT3.Plasmids were electroporated into MG1.19 cells and stable
transfectants were isolated after 8 days selection in medium
s of reproduction in any form reserved.
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36 Burdon et al.containing hygromycin B and LIF. Similar numbers of
hygromycin-resistant colonies were obtained for all the SHP-2
expression vectors. After staining with Leishman’s reagent, a
minimum of 300 randomly chosen colonies per construct
were scored according to whether they contained predomi-
nantly stem cells, both stem and differentiated cells, or only
differentiated cells (Fig. 4A). Compared with the empty vector
control, expression of SHP-2 (WT) or (Y-F) had little effect on
colony morphology other than a slight increase in the num-
bers of mixed colonies. In contrast, expression of the SHP-2
(C-S) mutant increased the proportion of colonies containing
stem cells and reduced the number of those composed of
differentiated cells. This suggests that inhibition of the phos-
phatase activity of SHP-2 enhances ES cell self-renewal.
To assess this in a more quantitative manner, D027
transfectants carrying stably integrated SHP-2 expression
vectors were established and their self-renewal in response
to LIF was measured via expression of the chromosomal
Oct4–LacZ reporter gene. Immunoblotting confirmed that
the introduced forms of SHP-2 were overexpressed by
approximately 10- to 20-fold in the D027 transfectants (Fig.
4B). As shown in Fig. 4C, expression of the SHP-2 (C-S)
mutant increased stem cell self-renewal compared with
cells transfected with control vector. Both SHP-2 (WT) or
(Y-F) slightly inhibited self-renewal. This result supports
the notion that the phosphatase activity of SHP-2 can
suppress ES cell self-renewal. There was, however, no
indication of the unusual colony morphology observed with
the GRgp(Y118F) receptor, indicating that another, as yet
unidentified, mechanism may moderate gp130-dependent
signalling through tyrosine 118.
Tyrosine 118 Is Necessary for Activation of ERK1
and ERK2
Since activation of SHP-2 can couple gp130 to the ERK
pathway (Fukada et al., 1996), we examined whether ty-
osine 118 was also required for activation of ERK1 and
RK2 in ES cells. Activation of ERKs in GRgp130 transfec-
ants treated with G-CSF or IL-6 (plus sIL-6R) was assessed
y immunoblotting with an antibody specific for the phos-
horylated (activated) forms of ERK1 and ERK2 (Fig. 5).
asal levels of activated ERK were consistently detected in
ntreated cells following serum starvation. Increased ERK
hosphorylation was observed in cells stimulated via the
ndogenous gp130 and GRgp(278) receptors. This was not
vident on stimulation through the GRgp(Y118F) chimaera.
eprobing with an antibody specific for the tyrosine phos-
horylated form of STAT3 confirmed that both chimaeric
eceptors were effective at activating STAT3. These results
stablish that tyrosine 118 mediates activation of the ERK
athway in ES cells.
Blockade of ERK Activation with PD098059 Does
Not Impair ES Cell PropagationThe capacity of GRgp(Y118F) to signal self-renewal im-
plies that ERK activation is not required for the propagation
t
P
Copyright © 1999 by Academic Press. All rightf ES cells. To test this hypothesis, D027 cells were cul-
FIG. 4. Overexpression of catalytically inactive SHP-2 promotes ES
cell self-renewal. (A) Self-renewal of MG1.19 cells expressing mutant
forms of SHP-2. MG1.19 cells were electroporated with either the
empty expression vector pCAGIH or constructs expressing WT,
Y542/580F, or C459S forms of SHP-2. Hygromycin-resistant colonies
(.300) were stained and scored on the basis of whether they contained
redominantly stem cells (undiff) or differentiated cells (diff) or were
omposed of both cell types. (B) Overexpression of SHP-2 in D027
ransfectants. Cell lysates prepared from representative clones were
ractionated on a 10% SDS–acrylamide gel, electroblotted onto a
itrocellulose membrane, and probed with a SHP-2-specific antibody.
C) Self-renewal of D027 cells overexpressing SHP-2. Self-renewal of
027 cells stably transfected with either pCAGIZ (vector) or the
CAGIZ-based SHP-2 expression constructs was assayed by measur-
ng b-galactosidase activity from the Oct4–LacZ locus. Cells were
ssayed after culture for 6 days in 100 units/ml LIF. Data for three
ndependent clones are represented as means 6 SEM for duplicate
eterminations of triplicate samples and normalised relative to the
ean value obtained for the pCAGIZ (vector) transfectants.ured in the presence of the specific MEK inhibitor,
D098059 (Dudley et al., 1995). Treatment of ES cells with
s of reproduction in any form reserved.
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37SHP-2 and ERK Activity in Pluripotent Cells3–25 mM PD098059 did not inhibit self-renewal compared
ith cells cultured in vehicle alone (Fig. 6A). Surprisingly,
n fact, the level of self-renewal increased in a dose depen-
ent manner peaking at 12–25 mM. At concentrations
greater than 50 mM PD098059 the growth of ES cells was
impaired, possibly as a result of some nonspecific inhibitory
effect of the drug, resulting in small colonies which were
undifferentiated as shown by staining for b-galactosidase
(data not shown).
To verify that ERK activation through gp130 was con-
tinuously suppressed by PD098059 in these long-term cul-
tures, GRgp(278) cells were incubated for 48 h with the
inhibitor plus LIF and then stimulated through the chimae-
ric receptor with G-CSF. The immunoblot revealed that
G-CSF-dependent phosphorylation of ERK1 and ERK2 was
progressively reduced from 3 to 12 mM and effectively
blocked at 25 mM PD098059 (Fig. 6B). The continued
proliferation of undifferentiated ES cells at inhibitory con-
centrations of PD098059 confirms that gp130-dependent
activation of ERK1 and ERK2 is not required for the
propagation of ES cells.
The effect of PD098059 on self-renewal suggested that
the inhibitor might alter the dose response of ES cells to
LIF. Self-renewal of ES cells was assayed following treat-
ment with 3–300 U/ml LIF in the presence of either 25 mM
PD098059 or vehicle (0.2% DMSO) (Fig. 6C). Treatment
with PD098059 increased the level of b-galactosidase activ-
ity at all concentrations of LIF. This implies that the drug
does not alter the cytokine dose dependency of ES cells but
rather enhances their response to LIF. Significantly,
FIG. 5. gp130-dependent phosphorylation of ERK1 and ERK2 in
ES cells. ES cells expressing either the GRgp(278) or the
GRgp(Y118F) chimaeric receptors were either untreated or stimu-
lated with IL-6 (100 ng/ml plus sIL-6R) or G-CSF (30 ng/ml) for 10
or 20 min. Cell lysates were separated on a 10% SDS–acrylamide
gel, electroblotted onto a nitrocellulose membrane, and probed
sequentially with antibodies specific for the active phosphorylated
forms of ERK and STAT3. Reprobing the stripped filter with an
antibody that binds to both phosphorylated and dephosphorylated
ERKs verified that equivalent amounts of protein were loaded in
the samples.PD098059 did not block the differentiation of ES cells in the
absence of LIF.
Copyright © 1999 by Academic Press. All rightES Cells Propagated in PD098059 Remain
Pluripotent
ES cell colony morphology and Oct4 expression are
reliable indicators of the undifferentiated phenotype, but do
not establish that the cells are pluripotent. We therefore
determined whether ES cells propagated in the absence of
gp130-dependent ERK signalling have the capacity to incor-
porate into the developing embryo and differentiate appro-
priately. Cells were cultured at low density (1000 cells/cm2)
for 48 h in the presence of LIF plus 25 mM PD098059 or in
the absence of LIF. They were then refed with medium
containing LIF but lacking the inhibitor for a further 24 h
before microinjection into mouse blastocysts. ZIN40 cells
were used in this experiment, since they carry a nuclear-
localised b-galactosidase marker widely expressed in differ-
entiated cell types (Mountford, 1995). Staining of midgesta-
tion embryos for b-galactosidase revealed that ES cells
treated with PD098059 contributed to chimaeras (Fig. 7). In
contrast, cells cultured in the absence of LIF for 48 h were
incapable of colonising the embryo (data not shown). Sig-
nificantly, live-born chimaeras have been obtained from ES
cells cultured for 4 days in 25 mM PD098059. Functional
contribution of the cells to the germ line has been observed
in two chimaeras, as evidenced by transmission of the ES
cell-derived coat colour marker. This result confirms that
gp130-dependent ERK activity is not required for maintain-
ing the pluripotency of ES cells.
PD098059 Inhibits the Differentiation of ES Cells
in Embryoid Bodies
The enhancement of ES cell self-renewal by PD098059
indicates that signals mediated through MEK may be in-
volved in controlling ES cell differentiation. However, the
physiological relevance of this process on a plastic substra-
tum is unclear. To examine the effect of PD098059 in a
more appropriate model of differentiation, ES cells were
aggregated to form embryoid bodies and cultured in the
presence of the MEK inhibitor. The IOUD2 ES cell line used
in this experiment carries the Oct4–LacZ chromosomal
reporter gene, thus allowing the identification of stem cells
in embryoid bodies by staining for b-galactosidase activity
(Dani et al., 1998). ES cells were aggregated in hanging drops
in the absence of LIF for 2 days and then maintained in
suspension in bacterial dishes in the presence of 25–100 mM
PD098059 for a further 5 days. Embryoid bodies were then
plated on gelatin-coated plates overnight and stained with
X-gal. Results of a representative experiment are shown in
Fig. 8. The proportion of stem cells increased in the pres-
ence of PD098059, in a dose-dependent manner, with the
majority of cells in embryoid bodies in 75 mM PD098059
staining positive for b-galactosidase. Importantly, the abso-
ute number of stem cells also increased (compare 25 mM
ith 75 mM), indicating that over this range of concentra-
tions of PD098059 the persistence of the stem cells was not
due to an inhibition of proliferation. At 100 mM PD098059,
however, the growth of embryoid bodies was severely
s of reproduction in any form reserved.
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38 Burdon et al.FIG. 6. Effect of the MEK inhibitor, PD098059, on ES cell self-renewal and ERK activation. (A) Self-renewal of ES cells treated with the
indicated concentrations of PD098059. D027 ES cells grown at a subsaturating level of LIF (5 U/ml), to increase the sensitivity of the assay
to changes in self-renewal signalling, were treated with PD098059 for 5 days and assayed for b-galactosidase expression from the Oct4 locus.
Data are means 6 SEM for duplicate determinations of triplicate samples normalised relative to the response in the absence of PD098059.
(B) PD098059-dependent inhibition of ERK activation. GRgp(278)-transfected D027 cells were cultured with a subsaturating level of LIF (5
U/ml) and PD098059 for 48 h. Cells were then stimulated with G-CSF (30 ng/ml) for 10 min, lysed in sample buffer, and analysed for ERK
activation by immunoblotting with phosphospecific anti-ERK antibodies. Subsequent probing of the filter with an antibody that binds to
both phosphorylated and dephosphorylated ERKs confirmed that equivalent amounts of protein were loaded in all samples. (C) Effect of
PD098059 on the dose response of ES cells to LIF. The dose response of D027 ES cells to LIF in 25 mM PD098059 or vehicle (0.05% DMSO)
as measured by b-galactosidase expression from the Oct4 locus. Data are means 6 SEM for duplicate determinations of triplicate samples
ormalised relative to the maximum response of cells to treatment with LIF (100 U/ml) plus vehicle. No significant difference in ES
elf-renewal was observed between untreated and DMSO-treated cells.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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39SHP-2 and ERK Activity in Pluripotent Cellsinhibited, although most of the surviving cells did still
express the Oct4–LacZ reporter gene (data not shown).
In embryoid bodies maintained for a further 5 days after
plating, the persistence of stem cells was significantly
FIG. 7. Effect of PD098059 on ES cell pluripotency. ZIN40 ES ce
with medium containing LIF for a further 24 h, and then microin
pregnancy and stained for b-galactosidase activity. Representative
IG. 8. Effect of PD098059 on ES cell differentiation in embryoi
ithout LIF for 2 days. They were then transferred to bacterial dish
5, 50, or 75 mM PD098059. After attachment overnight on gelatinisaugmented by PD098059 (data not shown). Cardiomyo-
cytes, identifiable as patches of beating cells, were found in
Copyright © 1999 by Academic Press. All rightoth untreated embryoid bodies and those cultured in the
resence of 25 mM PD098059, thus demonstrating that the
starting population of ES cells was capable of differentiating
appropriately.
ere treated with 25 mM PD098059 plus 5 U/ml LIF for 48 h, refed
d into C57BL/6 blastocysts. Embryos were collected at day 9.5 of
ryos are shown.
ies. Aggregates of IOUD2 ES cells were formed in hanging drops
d cultured for 5 days in medium containing either no inhibitor or
ates, the embryoid bodies were stained for b-galactosidase activity.lls w
jecte
emb
d bodThese results show that ES cell differentiation, under
conditions that reflect events in the early embryo, can be
s of reproduction in any form reserved.
40 Burdon et al.inhibited by blocking MEK activity. This suggests that ERK
signalling may play an important role in the differentiation
of pluripotent epiblast cells during gastrulation.
DISCUSSION
Engagement of the gp130 cytokine receptor subunit gen-
erates intracellular signals that block ES cell differentiation
and promote self-renewal of these pluripotent stem cells
(Yoshida et al., 1994). Identification of the underlying
mechanisms that regulate mouse ES cell propagation
should allow the development of improved strategies for
establishing pluripotent stem cell lines from other mam-
malian species including humans. In this regard, we have
previously demonstrated that gp130-dependent propagation
of ES cells does require STAT3 activation (Niwa et al.,
1998). Here we show that gp130-dependent recruitment of
SHP-2 and the stimulation of the MAP kinases, ERK1 and
ERK2, do not contribute directly to maintaining pluripo-
tency. Rather they function to moderate the strength of
gp130 signalling. In addition, we present evidence that ERK
activation may directly promote the differentiation of ES
cells.
Stimulation of ES cells through either endogenous gp130
or the chimaeric GRgp(278) receptor increased the tyrosine
phosphorylation of SHP-2. This modification was blocked
when tyrosine 118 of gp130 was mutated to phenylalanine,
confirming that this single tyrosine is essential for recruit-
ment of SHP-2 (Stahl et al., 1995). Despite this deficit, the
mutated receptor was fully capable of directing self-renewal
of ES cells, proving effective even at low concentrations of
activating ligand. This result establishes that SHP-2 activ-
ity is not required to maintain the pluripotent phenotype of
ES cells and may in fact inhibit self-renewal signalling. The
latter conclusion is supported by the enhanced self-renewal
of ES cells overexpressing the catalytically inactive SHP-2
(C-S) mutant. Collectively these results suggest that SHP-2
activity suppresses or antagonises mechanisms that pro-
mote ES cell self-renewal. These findings provide an expla-
nation for the phenotype of ES cells carrying a partial
deletion of the endogenous SHP-2 gene (Qu et al., 1997).
Although interpretation is complicated by the continued
expression of a truncated SHP-2 protein, the mutant ES
cells are viable, show a slight increase in their responsive-
ness to LIF, and exhibit an impaired capacity to differentiate
in vitro (Qu and Feng, 1998).
Despite an established role for SHP-2 in coupling recep-
tors to the Ras/MAPK signalling pathway, a negative regu-
latory function has also been implied through its homology
to SHP-1, a suppresser of erythropoietin receptor function
(Klingmuller et al., 1995). Indeed, mutation of tyrosine 118
of gp130 has been shown to enhance STAT3 signalling in
neuroblastoma and hepatoma cells (Kim et al., 1998; Servi-
dei et al., 1998). Furthermore, transcription from STAT3-
responsive promoter constructs was increased by overex-
pression of a catalytically inactive SHP-2 protein. This
Copyright © 1999 by Academic Press. All rightpointed to the phosphatase as a likely mediator of this
effect: a conclusion supported by sustained phosphorylation
of both the Y118F receptor and its associated JAK kinases
(Kim et al., 1998).
Interestingly, signalling via the GRgp(Y118F) receptor
was associated with restricted growth of ES cells in high
concentrations of G-CSF. This intriguing observation indi-
cates that excessive gp130 signalling can interfere with ES
cell propagation. Hyperactivation of STAT3 is implicated in
this phenotype because stimulation of the Y118F receptor
results in prolonged tyrosine phosphorylation of STAT3
and sustained activation of endogenous STAT3 target
genes, and is suppressed by combined mutagenesis of mul-
tiple STAT3 docking sites (T.B., C.S., I.C., A.S., unpub-
lished). Significantly, overexpression of catalytically inac-
tive SHP-2 enhanced self-renewal but did not recapitulate
the effect obtained with the GRgp(Y118F) receptor, indicat-
ing that a loss of phosphatase activity of SHP-2 may not be
solely responsible for the increased signalling activity.
Since ERKs are downstream of effectors of SHP-2 and
have been proposed to play a role in self-renewal (Boeuf et
al., 1997; Ernst et al., 1996), we examined the activation of
these MAP kinases by the chimaeric receptors. Whereas
stimulation of gp130 in ES cells triggered an increase in
ERK1 and ERK2 phosphorylation, no response could be
detected upon engagement of the Y118F chimaeric receptor.
Furthermore, treatment with inhibitory concentrations of
the MEK inhibitor PD098059 did not block but rather
enhanced self-renewal of ES cells. Activation of ERK1 and
ERK2, via either SHP-2 or another pathway such as Shc
(Giordano et al., 1997), therefore is not critical in maintain-
ing the pluripotent phenotype of ES cells.
This lack of a requirement for gp130-dependent ERK
activation may be related to the continuously proliferating
nature of ES cells. An established function of ERKs in
differentiated cells is to regulate the transition through
G1/S, at least in part through the induction of cyclin D
(Lavoie et al., 1996; Weber et al., 1997). However, ES cells
have a relatively short G1 phase and appear to possess few
of the G1-associated control mechanisms (Savatier et al.,
1994, 1996). Furthermore, this uncoupling from ERK signal-
ling is consistent with the observation that ES cells con-
tinue to proliferate in the absence of serum, a powerful
mitogen and inducer of ERK activity (Johansson and Wiles,
1995).
The increase in stem cell self-renewal on treatment with
the MEK inhibitor PD098059 implies that ERK activity
impairs the propagation of undifferentiated ES cells. Studies
of gp130-dependent signalling in PC12 cells and in astro-
cytes have shown that inhibition of ERK activity resulted in
enhanced STAT3-mediated transcription (Bonni et al.,
1997; Ihara et al., 1997).This suggests that antagonism
between STAT3 and ERK signalling could account for the
effect of PD098059 in ES cells. Alternatively, signalling via
ERKs may actively promote ES cell differentiation. Indeed,
the persistence of stem cells in embryoid bodies treated
s of reproduction in any form reserved.
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necessary component of the normal differentiation process.
Differentiation of ES cells is associated with induction of
G1 cyclin expression, indicating the reestablishment of G1
cell cycle control mechanisms (Savatier et al., 1996). This
ransition also occurs in the epiblast at gastrulation and
here is increasing evidence that the Ras/MAPK signalling
athway plays a critical role in regulating these differentia-
ion events. Inhibition of SHP-2 activity during embryonic
evelopment of either Xenopus or mice is associated with
failure to gastrulate normally and defects in the formation
of mesodermal cell lineages (Saxton et al., 1997; Tang et al.,
1995). Downregulation of ERK activity in Xenopus, through
overexpression of the MAP kinase phosphatase MKP-1, also
inhibits mesoderm induction (LaBonne et al., 1995). Fur-
thermore, mutation of the gene encoding a transcription
factor regulated by the Ras/MAPK signalling pathway,
serum response factor (SRF), blocks gastrulation and forma-
tion of mesoderm in the mouse (Arsenian et al., 1998).
Significantly, however, loss of SRF activity is not reported
to compromise the propagation of srf 2/2 ES cells. The
differentiation of epiblast cells may therefore represent a
point at which embryonic cells become subservient to
ERK-dependent growth control mechanisms. Interestingly,
this is also the stage at which transplanted grafts of embry-
onic tissue lose the capacity to form malignant teratocarci-
nomas (Damajanov et al., 1971).
The independence of ES cell self-renewal from ERK
activation may have important practical applications. Our
data suggest that inhibitors of the Ras/MAPK pathway
should promote the propagation of undifferentiated ES
cells. It is possible that by suppressing the growth and
maturation of differentiated cell types, such inhibitors may
facilitate the routine manipulation and de novo derivation
of ES cells.
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